DEXIVITE- ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium carbonate, ferrous gluconate, iodine tablet

Dexivite by

Drug Labeling and Warnings

Dexivite by is a Other medication manufactured, distributed, or labeled by Lifsa Drugs Llc . Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

HEALTH CLAIM:

Dexivite Tablets - Prenatal/Postnatal Dietary Supplement

Dispensed by Prescription

Supplement Facts 

Serving Size: 1 Tablet; Serving per Bottle: 30
Amount Per Serving:		% Daily Value
Vitamin C (as ascorbic acid)	125 mg	104%
Vitamin D3 (as cholecalciferol)	12.5 mcg (500 IU)	83%
Thiamine (Vitamin B1 as thiamine HCl)	1.4 mg	100%
Vitamin B6 (as pyridoxal-5-phosphate)	2.5 mg	125%
Folic Acid	1,666 DFE (1 mg folic acid)	278%
Vitamin B12 (as methylcobalamin)	1,000 mcg	35,714%
Calcium (from calcium carbonate)	200 mg	15%
Iron (as ferrous gluconate)	13 mg	48%
Iodine (as potassium iodide)	150 mcg	52%

OTHER INGREDIENTS: Microcrystalline Cellulose, Silicon Dioxide and Magnesium Stearate.

DESCRIPTION:

Dexivite Tablets is a prescription dietary supplement for use throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Dexivite Tablets may be useful in improving the nutritional status of women prior to conception.

WARNING AND PRECAUTIONS

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

CONTRAINDICATIONS:
Dexivite Tablets are contraindicated in patients with a known hypersensitivity to any of the ingredients. Do not take this product if you are presently taking mineral oil, unless directed by a doctor.

PRECAUTION:
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B is deficient. Folic acid in doses above 1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. Dexivite
Tablets should only be used under the direction and supervision of a licensed medical practitioner.

ADVERSE REACTIONS:
Allergic sensitization has been reported following both oral and parenteral administration of folic acid. You may report side effects by calling the FDA at 1-800-FDA-1088.

DOSAGE & ADMINISTRATION:

Usual adult dose is 1 tablet taken orally once or twice daily or as prescribed by a licensed medical practitioner.

HOW SUPPLIED HEALTH CLAIM:

Dexivite Tablets are available as white, round tablets and are available in 30-count bottles (72336-044-01*). This product is not an Orange Book product.

Dispensed by Prescription†

Manufactured for: Lifsa Drugs LLC, New Brunswick, NJ 08901

Rev. 08/19

* Lifsa Drugs LLC does not represent these product codes to be National Drug Codes (NDC). Product codes are formatted according to standard industry practice, to meet the formatting requirement by pedigree reporting and supply-chain control including pharmacies. † This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760).1-3 The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription. This is not an Orange Book product. This product may be administered only under a physician’s supervision and all prescriptions using this product shall be pursuant to state statutes as applicable. The ingredients, indication or claims of this product are not to be construed to be drug claims. 1. Federal Register Notice of August 2, 1973 (38 FR 20750) 2. Federal Register Notice of October 17, 1980 (45 FR 69043, 69044) 3. Federal Register Notice of March 5, 1996 (61 FR 8760)

STORAGE AND HANDLING:

Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.] Protect from heat, light and moisture. Tamper Evident: Do not use if seal is broken or missing.

Distributed by: Lifsa Drugs LLC, New Brunswick, NJ 08901

Packaging

INGREDIENTS AND APPEARANCE

DEXIVITE 
ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium carbonate, ferrous gluconate, iodine tablet

Product Information
Product Type	DIETARY SUPPLEMENT	Item Code (Source)	NHRIC:72336-044
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R)	ASCORBIC ACID	125 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41)	CHOLECALCIFEROL	0.0125 mg
THIAMINE (UNII: X66NSO3N35) (THIAMINE ION - UNII:4ABT0J945J)	THIAMINE	1.4 mg
PYRIDOXAL PHOSPHATE ANHYDROUS (UNII: F06SGE49M6) (PYRIDOXAL PHOSPHATE ANHYDROUS - UNII:F06SGE49M6)	PYRIDOXAL PHOSPHATE ANHYDROUS	2.5 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)	FOLIC ACID	1 mg
METHYLCOBALAMIN (UNII: BR1SN1JS2W) (METHYLCOBALAMIN - UNII:BR1SN1JS2W)	METHYLCOBALAMIN	1 mg
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB)	CALCIUM CATION	200 mg
FERROUS GLUCONATE (UNII: U1B11I423Z) (FERROUS CATION - UNII:GW89581OWR)	FERROUS CATION	13 mg
POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q)	IODIDE ION	0.15 mg

Inactive Ingredients
Ingredient Name	Strength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
MAGNESIUM STEARATE (UNII: 70097M6I30)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:72336-044-01	30 in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
dietary supplement		11/01/2019

Supplement Facts
Serving Size :		Serving per Container :
	Amount Per Serving	% Daily Value
color
shape
size (solid drugs)	20 mm
scoring	1

Labeler - Lifsa Drugs Llc (081205160)